Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: A randomized, placebo-controlled, double-blind study

Food and Chemical Toxicology

Volumn 49, Issue 9, 2011, Pages 2356-2364

  Burton, J P ^a   Cowley, S ^b   Simon, R R ^c   McKinney, J ^d   Wescombe, P A ^a   Tagg, J R ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b Clinical Development Associates Inc   (United States)

^c Cantox Health Sciences International   (Canada)

^d National Clinical Research Inc   (United States)

Author keywords

Probiotics; Safety; Streptococcus salivarius K12

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ABDOMINAL PAIN; ANXIETY; ARTICLE; ASTHMA; CLINICAL CHEMISTRY; CLINICAL EVALUATION; CONTROLLED STUDY; COUGHING; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; FEMALE; FLATULENCE; GASTROENTERITIS; HEADACHE; HEMATOLOGICAL PARAMETERS; HERPES SIMPLEX; HUMAN; INCREASED APPETITE; INFECTION; MALE; MYALGIA; NAUSEA; POLYMERASE CHAIN REACTION; PROCESS MONITORING; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SIDE EFFECT; STREPTOCOCCUS SALIVARIUS; URINALYSIS; VAGINITIS; VITAL SIGN; VOMITING;

BASE SEQUENCE; DNA PRIMERS; DOUBLE-BLIND METHOD; HUMANS; PLACEBOS; PROBIOTICS; QUESTIONNAIRES; REAL-TIME POLYMERASE CHAIN REACTION; STREPTOCOCCUS;

STREPTOCOCCUS SALIVARIUS;

EID: 79960836521     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.06.038     Document Type: Article

References (27)

1. Burton J., Chilcott C., Wescombe P., Tagg J. Extended safety data for the oral cavity probiotic Streptococcus salivarius K12. Probiot. Antimicro. Prot. 2010, 2:135-144.
2. Burton J.P., Chilcott C.N., Moore C.J., Speiser G., Tagg J.R. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. J. Appl. Microbiol. 2006, 100:754-764.
3. Burton J.P., Wescombe P.A., Moore C.J., Chilcott C.N., Tagg J.R. Safety assessment of the oral cavity probiotic Streptococcus salivarius K12. Appl. Environ. Microbiol. 2006, 72:3050-3053.
4. Callon C., Millet L., Montel M.C. Diversity of lactic acid bacteria isolated from AOC Salers cheese. J. Dairy Res. 2004, 71:231-244.
5. National Health and Nutrition Examination Survey 2007-2008. Documentation, Codebook, and Frequencies 2009, CDC, Oral Health.
6. Dalidowitz C. Fortified breast milk safety. J. Am. Diet. Assoc. 2005, 105:1572-1573.
7. Dierksen K.P., Tagg J. The influence of indigenous bacteriocin-producing Streptococcus salivarius on the acquisition of Streptococcus pyogenes by primary school children in Dunedin, New Zealand. Streptococ. Streptococ. Dis. Enter. New Millen. 2000, 81-85.
8. Drossman D., Patrick D., Whitehead W., Toner B., Diamant N., Hu Y. Further validation of the IBS-QOL: a disease specific quality of life questionnaire. Am. J. Gastroenterol. 2000, 95:999-1007.
9. Favier C.F., Vaughan E.E., De Vos W.M., Akkermans A.D. Molecular monitoring of succession of bacterial communities in human neonates. Appl. Environ. Microbiol. 2002, 68:219-226.
10. Festing M.F., Altman D.G. Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR J. 2002, 43:244-258.
11. Heikkila M.P., Saris P.E. Inhibition of Staphylococcus aureus by the commensal bacteria of human milk. J. Appl. Microbiol. 2003, 95:471-478.
12. Hyink O., Wescombe P.A., Upton M., Ragland N., Burton J.P., Tagg J.R. Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12. Appl. Environ. Microbiol. 2007, 73:1107-1113.
13. Kononen E., Jousimies-Somer H., Bryk A., Kilp T., Kilian M. Establishment of streptococci in the upper respiratory tract: longitudinal changes in the mouth and nasopharynx up to 2 years of age. J. Med. Microbiol. 2002, 51:723-730.
14. Martin R., Heilig H.G., Zoetendal E.G., Jimenez E., Fernandez L., Smidt H., Rodriguez J.M. Cultivation-independent assessment of the bacterial diversity of breast milk among healthy women. Res. Microbiol. 2007, 158:31-37.
15. Ongol M.P., Asano K. Main microorganisms involved in the fermentation of Ugandan ghee. Int. J. Food Microbiol. 2009, 133:268-291.
16. Park H.K., Shim S.S., Kim S.Y., Park J.H., Park S.E., Kim H.J., Kang B.C., Kim C.M. Molecular analysis of colonized bacteria in a human newborn infant gut. J. Microbiol. 2005, 43:345-353.
17. Pesic-Mikulec D. Microbiological study of fresh white cheese. Appl. Ecol. Environ. Res. 2005, 4:129-134.
18. Preza D., Olsen I., Willumsen T., Grinde B., Paster B.J. Diversity and site-specificity of the oral microflora in the elderly. Eur. J. Clin. Microbiol. Infect. Dis. 2009, 28:1033-1040.
19. Schulz K.F., Altman D.G., Moher D., Group C. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann. Intern. Med. 2010, 152:726-732.
20. Shane A.L., Cabana M.D., Vidry S., Merenstein D., Hummelen R., Ellis C.L., Heimbach J.T., Hempel S., Lynch S.V., Sanders M.E., Tancredi D.J. Guide to designing, conducting, publishing and communicating results of clinical studies involving probiotic applications in human participants. Gut. Microbes. 2010, 1:243-253.
21. Treiber G., Schwabe M., Ammon S., Walker S., Klotz U., Malfertheiner P. Dyspeptic symptoms associated with Helicobacter pylori infection are influenced by strain and host specific factors. Aliment. Pharmacol. Ther. 2004, 19:219-231.
22. Vankerckhoven V., Huys G., Vancanneyt M., Snauwaert C., Swings J., Klare I., Witte W., Van Autgaerden T., Chapelle S., Lammens C., Goossens H. Genotypic diversity, antimicrobial resistance, and virulence factors of human isolates and probiotic cultures constituting two intraspecific groups of Enterococcus faecium isolates. Appl. Environ. Microbiol. 2008, 74:4247-4255.
23. Wescombe P.A., Heng N.C., Burton J.P., Chilcott C.N., Tagg J.R. Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics. Future Microbiol. 2009, 4:819-835.
24. Guidelines for the Evaluation of Probiotics in Food Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food 2002, WHO, Food and Agriculture Organization of the United Nations World Health Organisation, London, Canada.
25. Wind R.D., Tolboom H., Klare I., Huys G., Knol J. Tolerance and safety of the potentially probiotic strain Lactobacillus rhamnosus PRSF-L477: a randomised, double-blind placebo-controlled trial in healthy volunteers. Br. J. Nutr. 2010, 104:1806-1816.
26. Wolf B.W., Garleb K.A., Ataya D.G., Casas I.A. Safety and tolerance of Lactobacillus reuteri in healthy adult male subjects. Microb. Ecol. Health Dis. 1995, 8:41-50.
27. Wolf B.W., Wheeler K.B., Ataya D.G., Garleb K.A. Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus. Food Chem. Toxicol. 1998, 36:1085-1094.